HomeCompareCDNIF vs MRK

CDNIF vs MRK: Dividend Comparison 2026

CDNIF yields 6.94% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CDNIF wins by $186.93M in total portfolio value
10 years
CDNIF
CDNIF
● Live price
6.94%
Share price
$34.17
Annual div
$2.37
5Y div CAGR
74.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$186.99M
Annual income
$168,425,188.16
Full CDNIF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CDNIF vs MRK

📍 CDNIF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCDNIFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CDNIF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CDNIF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CDNIF
Annual income on $10K today (after 15% tax)
$589.55/yr
After 10yr DRIP, annual income (after tax)
$143,161,409.94/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CDNIF beats the other by $143,153,081.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CDNIF + MRK for your $10,000?

CDNIF: 50%MRK: 50%
100% MRK50/50100% CDNIF
Portfolio after 10yr
$93.52M
Annual income
$84,217,493.15/yr
Blended yield
90.05%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CDNIF
No analyst data
Altman Z
2.6
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CDNIF buys
0
MRK buys
0
No recent congressional trades found for CDNIF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCDNIFMRK
Forward yield6.94%2.76%
Annual dividend / share$2.37$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR74.2%32.7%
Portfolio after 10y$186.99M$56.8K
Annual income after 10y$168,425,188.16$9,798.13
Total dividends collected$185.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CDNIF vs MRK ($10,000, DRIP)

YearCDNIF PortfolioCDNIF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,908$1,208.24$11,206$366.19+$702.00CDNIF
2$15,084$2,342.41$12,650$502.35+$2.4KCDNIF
3$20,971$4,830.62$14,407$694.19+$6.6KCDNIF
4$33,372$10,933.48$16,585$967.82+$16.8KCDNIF
5$64,035$28,326.54$19,342$1,363.89+$44.7KCDNIF
6$157,006$88,488.99$22,913$1,947.19+$134.1KCDNIF
7$521,224$353,227.53$27,662$2,823.89+$493.6KCDNIF
8$2,466,801$1,909,091.14$34,159$4,173.35+$2.43MCDNIF
9$17,349,069$14,709,591.63$43,337$6,308.80+$17.31MCDNIF
10$186,988,692$168,425,188.16$56,776$9,798.13+$186.93MCDNIF

CDNIF vs MRK: Complete Analysis 2026

CDNIFStock

Logista Integral SA engages in the provision of logistics services. The company provides various products & services, including tobacco and related tobacco products, convenience goods, documents and electronic devices (such as mobile phone and travel card top-ups), drugs, books, newspapers, and lottery tickets. It operates through the following geographical segments: Spain, France, Italy & Portugal. The company was founded in 1999 and is headquartered in Leganes, Spain.

Full CDNIF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CDNIF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CDNIF vs SCHDCDNIF vs JEPICDNIF vs OCDNIF vs KOCDNIF vs MAINCDNIF vs JNJCDNIF vs ABBVCDNIF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.